Skip to main content

Table 1 Clinical characteristics of the included patients*

From: An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer

Median age: 58 years, range 29-82  
  Number of patients (%)
T  
   1 77 (50.3%)
   2 76 (49.7%)
N  
   0 96 (62.7%)
   1 57 (37.3%)
Stage  
   I 61 (39.9%)
   IIa 51 (33.3%)
   IIb 41 (26.8%)
Hormone receptor status  
   ER+/PgR- 30 (19.6%)
   ER+/PgR+ 110 (71.9%)
   ER+/PgR unknown 12 (7.9%)
   ER-/PgR+ 1 (0.7%)
Grade  
   1 29 (18.9%)
   2 64 (41.8%)
   3 59 (38.6%)
   Unknown 1 (0.7%)
Chemotherapy  
   No chemotherapy 56 (36.6%)
   CMF 42 (27.4%)
   Anthracycline-based 55 (35.9%)
  1. * All patients received adjuvant tamoxifen.
  2. CMF: cyclophosphamide, methotrexate, 5-fluorouracil